Sign In

James Peyer, PhD

CEO at Cambrian Bio - creating the new generation of preventative medicines

Dr. James Peyer, PhD, is the Founder and CEO of Cambrian Bio, a pioneering Distributed Drug Development Company (DisCo) focusing on therapeutics for aging. He spearheads the translation of lab breakthroughs into clinical solutions, aiming to shift medical research towards proactive health management.

Prior to founding Cambrian Bio, James established Apollo Ventures, a trailblazing venture builder in Longevity Therapeutics, where he led as founder, investor, and CEO of multiple ventures. He holds a Doctor of Philosophy (PhD) in Stem Cell Biology from UT Southwestern Medical Center, supported by a Bachelor of Arts (B.A.) in Biology from the University of Chicago.

Dr. Peyer's rich professional background includes roles such as Former Board Director at the Longevity Biotechnology Association, Former Founder & CEO of Cambrian Bio, Former Founder & Managing Partner at Apollo Ventures, Former Consultant at McKinsey & Company, and Former Founder and CEO at Genotyp. His expertise, experience, and leadership have been instrumental in driving innovation in the field of longevity therapeutics.

James Peyer, PhD
Add to my network

Location

New York City Metropolitan Area